Search results
Results: 88
Number of items: 88
-
Makuch, M., van Beek, J., Wijbrandts, C. A., Aalbers, M., Stas, P., Meijer, A. B., Brinke, A. T., Rispens, T., Tak, P. P., Wolbink, G., Schuurman, J., Parren, P. W. H. I., & van Ham, M. S. (2025). The TNFα-binding domain of the therapeutic antibody adalimumab elicits CD4 T-cell responses in rheumatoid arthritis patients. Frontiers in Immunology, 16, Article 1549781. https://doi.org/10.3389/fimmu.2025.1549781 -
Verstegen, N. J. M., Hagen, R. R., Kreher, C., Kuijper, L. H., Dijssel, J. V. D., Ashhurst, T., Kummer, L. Y. L., Palomares Cabeza, V., Steenhuis, M., Duurland, M. C., Jongh, R. D., Schoot, C. E. V. D., Konijn, V. A. L., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2024). T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination. Journal of Neurology, Neurosurgery and Psychiatry, 95(9), 855–864. https://doi.org/10.1136/jnnp-2023-332224
-
van den Dijssel, J., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses. Journal of autoimmunity, 144, Article 103175. https://doi.org/10.1016/j.jaut.2024.103175
-
Kummer, L. Y. L., Fernández Blanco, L., Kreher, C., Bos, A., Kuijper, L. H., Verstegen, N. J. M., van de Sandt, C. E., Konijn, V. A. L., Duurland, M. C., Menage, C., Jorritsma, T., Steenhuis, M., Hagen, R. R., van den Dijssel, J., de Jongh, R., Ashhurst, T., van Gils, M. J., Garcia-Vallejo, J. J., Claireaux, M., ... T2B! immunity against SARS-CoV-2 study group (2024). Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID. RMD OPEN, 10(4), Article e004664. https://doi.org/10.1136/rmdopen-2024-004664
-
van Dam, K. P. J., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van der Kooi, A. J., Raaphorst, J., van de Beek, D., Verschuuren, J. J. G. M., Ruiter, A. M., Brusse, E., van Doorn, P. A., Baars, A. E., van der Pol, W. L., Goedee, H. S., ten Brinke, A., van Ham, S. M., Rispens, T., Kuijpers, T. W., Eftimov, F., & the T2B! Immunity Against SARS-CoV-2 Study Group (2024). Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases. European Journal of Neurology, 31(12), Article e16409. https://doi.org/10.1111/ene.16409
-
Valk, A. M., Tas, S. W., van Ham, S. M., ten Brinke, A., & T2B! immunity against SARS-CoV-2 study group (2024). Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination. Allergy, 79(7), 1952–1961. https://doi.org/10.1111/all.16089
-
Verkerk, T., Pappot, A. T., Jorritsma, T., King, L. A., Duurland, M. C., Spaapen, R. M., & van Ham, S. M. (2024). Isolation and expansion of pure and functional γδ T cells. Frontiers in Immunology, 15, Article 1336870. https://doi.org/10.3389/fimmu.2024.1336870
-
Keijzer, S., Oskam, N., Ooijevaar-de Heer, P., Steenhuis, M., Keijser, J. B. D., Wieske, L., van Dam, K. P. J., Stalman, E. W., Kummer, L. Y. L., Boekel, L., Kuijpers, T. W., ten Brinke, A., van Ham, S. M., Eftimov, F., Tas, S. W., Wolbink, G. J., Rispens, T., & T2B! immunity against SARS-CoV-2 study group (2024). Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. Frontiers in Immunology, 15, Article 1314507. https://doi.org/10.3389/fimmu.2024.1314507
Page 2 of 9